Datar Cancer Genetics Private Limited, a active private limited company, was established on 24 June 1992 in Nashik, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U01110MH1992PTC067409. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹125.80 Cr and a paid-up capital of ₹120.41 Cr.
Formerly known as Datar Agro Plantations Limited, Datar Cancer Genetics Limited. It upholds a compliant status. Its leadership includes Sneha Rajan Datar (Director), Swati Satish Deshpande (Director), Rajan Bhalchandra Datar (Director). Past directors included Dayanand Sunil Sahane, Kamlesh Narsinh Morarji, Rajan Bhalchandra Datar. It holds ₹18.14 Cr open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 15 July 2024, with the balance sheet filed on 31 March 2024. It is based at F-8, D-Road, Ambad,, Nashik, Maharashtra, 422010.
U01110MH1992PTC067409
067409
24 June 1992
₹125.80 Cr
₹120.41 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Datar Cancer Genetics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sneha Rajan Datar | Director | 01 Apr 2013 | Current |
| Swati Satish Deshpande | Director | 23 Oct 2020 | Current |
| Rajan Bhalchandra Datar | Director | 25 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 01 Jun 2013 | Past |
| Pramod Abcsdd | Managing Director | 26 Oct 2020 | Past |
| Pramod Abcsdd | Company Secretary | 04 Nov 2020 | Past |
| Pramod Abcsdd | Director | 26 Oct 2020 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Datar Cancer Genetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.76% increase. The company also saw a substantial improvement in profitability, with a 2173.38% increase in profit. The company's net worth Soared by an impressive increase of 31.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Datar Cancer Genetics had a promoter holding of 98.03% and a public holding of 1.97%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹181,375,000.00
₹13,810,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2025 | Others | ₹18.14 Cr | Open |
| 16 Jan 2023 | Hdfc Bank Limited | ₹9.29 M | Satisfied |
| 20 Dec 2022 | Hdfc Bank Limited | ₹4.53 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Datar Cancer Genetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Datar Cancer Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Datar Cancer Genetics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 18.14 Cr with Charge ID 101186462 was registered on 18 Oct 2025. was recorded as a recent event.
Vibhuti Rahul Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 23 Aug 2025 & has been associated with this company since 3 months 9 days . was recorded as a recent event.
Progress on A charge registered on 16 Jan 2023 via Charge ID 100674091 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024. was documented.
A charge registered on 20 Dec 2022 via Charge ID 100665917 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024. was recorded as a recent event.
Datar Cancer Genetics Private Limited last Annual general meeting of members was held on 15 Jul 2024 as per latest MCA records. was recorded as a recent event.
Datar Cancer Genetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Mumbai: 17th July 2019, Datar Cancer Genetics (Europe) GmbH has set up its operations in Germany. It will advance access to Datar Cancer Genetics Ltd’s (DCGL) innovative solutions across the European.
The CIN of Datar Cancer Genetics Private Limited is U01110MH1992PTC067409.
Datar Cancer Genetics Private Limited is headquartered at F-8, D-Road, Ambad,, Nashik, Maharashtra, 422010.
Datar Cancer Genetics Private Limited was incorporated on 24 June 1992.
The current directors of Datar Cancer Genetics Private Limited are
The primary industry of Datar Cancer Genetics Private Limited is Hospital And Medical Care.
Datar Cancer Genetics Private Limited is unlisted.
The authorized capital of Datar Cancer Genetics Private Limited is ₹125.80 Cr, and the paid-up capital is ₹120.41 Cr.
The compliance status of Datar Cancer Genetics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX